COMMUNIQUÉS West-GlobeNewswire

BrewDog and Tilray Beer Are Ready to Pour the World’s Biggest Bar Tab — £1 Million of Free Pints
24/06/2026
Jersey on. Crew ready. If England, Scotland or the U.S. reaches the final, fans can head straight to participating BrewDog pubs 1 and Tilray-owned brewpubs 2 across the U.S. to claim up to two free pints before the £1 [...]
Noom Members Regained 3x Less Weight After Stopping GLP-1s vs Standard-of-Care, New Analyses Show
24/06/2026
In two analyses, Noom members were modeled to gain less than 2% of bodyweight up to 12 months after stopping medication — with the strongest maintenance among those who continued practicing healthy habits Noom members [...]
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
24/06/2026
Greater than 60% increase in laboratory space will strengthen R&D capabilities, facilitate acceleration toward clinical development, and increase ability to tap into Heidelberg’s world-class medical oncology [...]
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
24/06/2026
- APPROACH Phase 3 clinical trial of HLP003 for the adjunctive treatment of major depressive disorder (“MDD”) is progressing as planned and has surpassed 86% enrollment - - Phase 2 HLP003 data demonstrated long-term [...]
OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals Nationwide
24/06/2026
WARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform
24/06/2026
Acquisition Strengthens Company's Intellectual Property Portfolio and Creates New Opportunities for Medical Device and Therapeutic Product Development Across Animal and Human Health Markets MINNEAPOLIS, MN, US, June 24 [...]
MapLight Therapeutics Announces Changes to Board of Directors
24/06/2026
SAN FRANCISCO and BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating [...]
Picard Medical Announces Leadership Transition
24/06/2026
Chairman, Richard Fang Appointed Interim Chief Executive Officer TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of [...]
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
24/06/2026
- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Disease - - Company Developing NPI as a Measure of DLB Psychosis - PURCHASE, N.Y., June 24, 2026 (GLOBE NEWSWIRE) -- [...]
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume
24/06/2026
Ranked second globally in 24-hour spot trading volume, Gate further extends market access and secondary liquidity for Enlivex ’ s primary digital treasury asset Nes-Ziona, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- [...]
RAMSAY SANTE lance le refinancement de sa dette senior
24/06/2026
COMMUNIQUÉ DE PRESSE Paris, le 24 juin 2026 Ramsay Santé lance le refinancement de sa dette senior Ramsay Santé annonce aujourd’hui le lancement du refinancement de sa dette senior pour un montant total de 1,75 [...]
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
24/06/2026
Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience Dr. Vinod Thourani appointed Clinical [...]
Bionano Announces Hiring of Chief Scientific Officer
24/06/2026
SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D. , as its Chief Scientific Officer (CSO) , [...]
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
24/06/2026
BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces that shareholders approved all proposals presented [...]
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
24/06/2026
Findings highlight RedTail’s potential to overcome historical limitations of T-cell engagers in solid tumors through tumor-specific, localized expression SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Calidi [...]
Mammogen Appoints Physician Executive and Breast Imaging Leader, Dr. Elise Berman, as Chief Medical Officer
24/06/2026
Berman Joins Mammogen to Support Next Phase of Growth Following $30 Million Series A Financing to Advance RNA-Based Breast Cancer Detection Platform NEWPORT BEACH, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Mammogen , a [...]
SRX Global Announces Share Consolidation
24/06/2026
NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-conviction operating [...]
Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress
24/06/2026
Expands Response Biomedical beyond acute care into chronic disease and wellness testing Introduces a next-generation platform for metabolic and inflammatory biomarker testing Combines speed, portability, and workflow [...]
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
24/06/2026
Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled trial in HIT, a life [...]

Pages